Rgeting this cytokine, for instance with exogenous IL-18BP, may well strengthen therapeutic outcomes for T1D
Rgeting this cytokine, for instance with exogenous IL-18BP, may well strengthen therapeutic outcomes for T1D individuals.Supplementary MaterialRefer to Web version on PubMed Central for supplementary material.AcknowledgmentsThis perform was supported by…